state+park+on+cape+san+blas

2025-01-09 04:49:57

拼音 [ 拼音 ]

State-of-the-Art of Monoclonal Antibodies for the Treatment...

Catenacci DVT, Kang YK, Park H, et al.; CP-MGAH22-5 Study Group. Margetuximab plus pembrolizumab in patients with pre viously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial. Lancet Oncol. 2020;21(8):1066–1076. doi:...
State-of-the-Art of Monoclonal Antibodies for the Treatment...

Catenacci DVT, Kang YK, Park H, et al.; CP-MGAH22-5 Study Group. Margetuximab plus pembrolizumab in patients with pre viously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial. Lancet Oncol. 2020;21(8):1066–1076. doi:...